Key statistics
On Thursday, Hofseth Biocare ASA (HBCo:STO) closed at 1.42, 4.43% above its 52-week low of 1.36, set on Oct 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.42 |
---|---|
High | 1.42 |
Low | 1.42 |
Bid | -- |
Offer | -- |
Previous close | 1.42 |
Average volume | 10.00k |
---|---|
Shares outstanding | 395.08m |
Free float | 173.87m |
P/E (TTM) | -- |
Market cap | 564.97m NOK |
EPS (TTM) | -0.3023 NOK |
Data delayed at least 15 minutes, as of Oct 31 2024 17:00 BST.
More ▼
Announcements
- Hofseth Biocare ASA: CFO RESIGNATION
- Hofseth Biocare ASA: HBC IMMUNOLOGY COMPLETES IN VIVO DRUG LEAD STUDIES FOR PROSTATE CANCER TREATMENT
- Hofseth Biocare ASA: SECOND QUARTER AND HALF YEAR 2024 FINANCIAL REPORT
- Hofseth Biocare ASA: GROUNDBREAKING STUDY REVEALS HOFSETH BIOCARE’S FULL SPECTRUM OMEGAS OMEGO SUPPORTS COVID-19 RECOVERY
- Hofseth Biocare ASA: HBC discovers new drug candidate for asthma and transfers it to HBC Immunology Inc.
- Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY
- Hofseth Biocare ASA: FIRST QUARTER 2024 FINANCIAL REPORT
- Hofseth Biocare ASA: Annual General Meeting completed
- Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2024
- Hofseth Biocare ASA: HBC ANNUAL REPORT 2023
More ▼